Home › NDC Lookup › Ingredients › Ustekinumab-Ttwe
📦 NDC / package directory — not a drug information page

Ustekinumab-Ttwe NDCs, Package Codes, Strengths & Labelers

This page lists NDC package records for Ustekinumab-Ttwe products — strengths, dosage forms, package sizes, labelers, 11-digit billing NDCs, pricing data when available, and links to each individual NDC page. It’s an NDC/package & billing directory, not a clinical drug page.

Key stats

15
Package NDCs
17
Products
17
Active listings
0
Discontinued
4
Labelers
3
Strengths
1
Dosage forms
0
With NADAC pricing

By strength, form & labeler

NDC products by strength
USTEKINUMAB 45 mg/.5mL 7
USTEKINUMAB 90 mg/mL 6
USTEKINUMAB 130 mg/26mL 4
By dosage form
INJECTION, SOLUTION 17
Top labelers
SANDOZ INC 6
Cordavis Limited 4
Quallent Pharmaceuticals Health LL... 4
Patheon Italia S.p.A 3

Browse records — 17 products

Drug / product Billing NDC NADAC / unit Status
PYZCHIVA ustekinumab-ttwe 90 mg/mL INJECTION, SOLUTION SANDOZ · NDC 61314-0652-01 · 1 SYRINGE in 1 CARTON (61314-652-01) / 1 mL in 1 SYRINGE 61314-0652-01 — On market View →
PYZCHIVA ustekinumab-ttwe 90 mg/mL INJECTION, SOLUTION Cordavis · NDC 83457-0652-01 · 1 SYRINGE in 1 CARTON (83457-652-01) / 1 mL in 1 SYRINGE 83457-0652-01 — On market View →
PYZCHIVA ustekinumab-ttwe 45 mg/.5mL INJECTION, SOLUTION Cordavis · NDC 83457-0651-01 · 1 SYRINGE in 1 CARTON (83457-651-01) / .5 mL in 1 SYRINGE 83457-0651-01 — On market View →
PYZCHIVA ustekinumab-ttwe 130 mg/26mL INJECTION, SOLUTION SANDOZ · NDC 61314-0654-94 · Q9997 · 1 VIAL, SINGLE-USE in 1 CARTON (61314-654-94) / 26 mL in 1 VIAL, SINGLE-USE 61314-0654-94 — On market View →
PYZCHIVA ustekinumab-ttwe 45 mg/.5mL INJECTION, SOLUTION SANDOZ · NDC 61314-0651-01 · 1 SYRINGE in 1 CARTON (61314-651-01) / .5 mL in 1 SYRINGE 61314-0651-01 — On market View →
PYZCHIVA ustekinumab-ttwe 45 mg/.5mL INJECTION, SOLUTION SANDOZ · NDC 61314-0651-01 · 1 SYRINGE in 1 CARTON (61314-651-01) / .5 mL in 1 SYRINGE 61314-0651-01 — On market View →
PYZCHIVA ustekinumab-ttwe 130 mg/26mL INJECTION, SOLUTION SANDOZ · NDC 61314-0654-94 · Q9997 · 1 VIAL, SINGLE-USE in 1 CARTON (61314-654-94) / 26 mL in 1 VIAL, SINGLE-USE 61314-0654-94 — On market View →
PYZCHIVA ustekinumab-ttwe 90 mg/mL INJECTION, SOLUTION SANDOZ · NDC 61314-0652-01 · 1 SYRINGE in 1 CARTON (61314-652-01) / 1 mL in 1 SYRINGE 61314-0652-01 — On market View →
PYZCHIVA ustekinumab-ttwe 90 mg/mL INJECTION, SOLUTION Cordavis · NDC 83457-0652-01 · 1 SYRINGE in 1 CARTON (83457-652-01) / 1 mL in 1 SYRINGE 83457-0652-01 — On market View →
PYZCHIVA ustekinumab-ttwe 45 mg/.5mL INJECTION, SOLUTION Cordavis · NDC 83457-0651-01 · 1 SYRINGE in 1 CARTON (83457-651-01) / .5 mL in 1 SYRINGE 83457-0651-01 — On market View →
USTEKINUMAB-TTWE 45 mg/.5mL INJECTION, SOLUTION Quallent · NDC 82009-0161-94 · .5 mL in 1 VIAL (82009-161-94) 82009-0161-94 — On market View →
ustekinumab-ttwe 45 mg/.5mL INJECTION, SOLUTION Patheon · NDC 68225-0250-00 · 2400 SYRINGE, GLASS in 1 BOX (68225-250-00) / 1 mL in 1 SYRINGE, GLASS 68225-0250-00 — On market View →
ustekinumab-ttwe 130 mg/26mL INJECTION, SOLUTION Patheon · NDC 68225-0253-00 · 61 VIAL in 1 BOX (68225-253-00) / 30 mL in 1 VIAL 68225-0253-00 — On market View →
ustekinumab-ttwe 90 mg/mL INJECTION, SOLUTION Patheon · NDC 68225-0251-00 · 2400 SYRINGE, GLASS in 1 BOX (68225-251-00) / 1 mL in 1 SYRINGE, GLASS 68225-0251-00 — On market View →
USTEKINUMAB-TTWE 45 mg/.5mL INJECTION, SOLUTION Quallent · NDC 82009-0160-11 · 1 SYRINGE in 1 CARTON (82009-160-11) / .5 mL in 1 SYRINGE 82009-0160-11 — On market View →
USTEKINUMAB-TTWE 90 mg/mL INJECTION, SOLUTION Quallent · NDC 82009-0162-11 · 1 SYRINGE in 1 CARTON (82009-162-11) / 1 mL in 1 SYRINGE 82009-0162-11 — On market View →
USTEKINUMAB-TTWE 130 mg/26mL INJECTION, SOLUTION Quallent · NDC 82009-0163-94 · Q9997 · 1 VIAL, SINGLE-USE in 1 CARTON (82009-163-94) / 26 mL in 1 VIAL, SINGLE-USE 82009-0163-94 — On market View →
Where does this data come from?
NDC package records, strengths, forms and labelers come from the openFDA NDC Directory; pricing is CMS NADAC. Grouped by active-ingredient name. This is package/billing reference data, not clinical drug information.